- Research works
- 21 ▲ 2181% vs 2013–17
- Citations
- 1.2k 56.0 per fractional work
- Top-10% rate
- 6.1% record average 16.5%
- Open access
- 57% world 28%
Not ranked overall: Humanigen (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Humanigen (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Genomic Integration, Embryonic Stem Cells, Pandemic, ACE2 Receptor, SARS-CoV-2, Gene Expression, Immunotherapy and Gene Therapy.
- Health Biotechnology
- Vaccine
- Clinical Characteristics
- Chimeric Antigen Receptor
- RNA-Guided
- Cancer Immunotherapy
- Immune Response
- Gene Therapy
- Epidemiology
- SARS-CoV-2
- ACE2 Receptor
- Embryonic Stem Cells
- Genomic Integration
- Pandemic
- Gene Expression
- Immunotherapy
- Biopharmaceutical Production
- Genetic Modification
- Transgenic Animals
- Genome Engineering
- CAR T Cells
- Tumor Regression
- Thrombosis
- Global Collaboration
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Genomic Integration2▲ 118×2 topics
- Embryonic Stem Cells2▲ 149×2 topics
- Pandemic2▲ 24×3 topics
- ACE2 Receptor2▲ 87×2 topics
- Gene Expression2▲ 16×3 topics
- SARS-CoV-22▲ 69×2 topics
- Immunotherapy2▲ 14×4 topics
- Epidemiology2▲ 2.2×4 topics
- Biopharmaceutical Production2▲ 103×2 topics
- Gene Therapy2▲ 32×3 topics
- Genetic Modification2▲ 199×1 topic
- Immune Response2▲ 12×3 topics
- Transgenic Animals2▲ 199×1 topic
- Cancer Immunotherapy1▲ 47×2 topics
- Genome Engineering1▲ 118×1 topic
- RNA-Guided1▲ 118×1 topic
- CAR T Cells1▲ 141×1 topic
- Chimeric Antigen Receptor1▲ 141×1 topic
- Tumor Regression1▲ 74×2 topics
- Clinical Characteristics1▲ 88×1 topic
- Thrombosis1▲ 27×1 topic
- Vaccine1▲ 14×3 topics
- Global Collaboration1▲ 119×1 topic
- Health Biotechnology1▲ 256×1 topic
Which research topics does Humanigen (United States) publish most on?
By volume in 2022–2025: COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Single-cell and spatial transcriptomics and Cancer Genomics and Diagnostics.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 COVID-19 Clinical Research Studies Infectious Diseases 1 works
- 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 3 Single-cell and spatial transcriptomics Molecular Biology 0 works
- 4 Cancer Genomics and Diagnostics Cancer Research 0 works
- 5 Cancer-related molecular mechanisms research Cancer Research 0 works
- 6 Long-Term Effects of COVID-19 Neurology 0 works
- 7 Sepsis Diagnosis and Treatment Epidemiology 0 works
- 8 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
- 9 COVID-19 and healthcare impacts Oncology 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Humanigen (United States)'s research output changed?
Output in 2018–2022 was 2181% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Burlingame
- Peninsula Library System
- Sphere Institute
- Color (United States)
- Pulse Biosciences (United States)
- Mills Peninsula Health Services
- Galaxy Advanced Engineering (United States)
- Collaborative Drug Discovery (United States)
- Acumen (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.